AXP Analysis

Alexion Pharmaceuticals, Inc.
Stock Exchange: XETRA
Sector: biotechnology
153.9
Last session price
153.9
Price now
Currency: EUR
Reporting currency: USD
ISIN: US0153511094
INN:
.

AXP financial statements

* Numbers in millions
Capitalization * 33 873
EV * 27 695
Number of shares * 220
EPS 2,74
Revenue * 6 070
Net income * 603
Operating profit * 2 860
Total liabilities * 6 452
Net debt * -403
Total assets * 18 103
Equity * 11 651
Cash and investments * 2 999
.

AXP valuation

P/E 56,14
P/B 2,91
P/S 5,58
E/P 2
P/FCF 11,70
.

AXP profitability

ROE 5%
ROA% 6%
ROIC% 17%